New hires and promotions in the biopharma industry, including: Fibrogen, Okyo, Xortx.
Quarterly snapshots from biopharma companies with marketed products, including: Adamas, Amag, Beigene, Clovis, Coherus, Exelixis, Dynavax, Fibrogen, GW, Ocular, Puma.
Biopharmas raising money in public or private financings, including: Arya, Biohaven, Checkmate, FSD, Freeline, Horizon.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Cstone, Everest, Ligand, Oncolys, Oncopeptides, Roche, Satsuma.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Cancer Targeted Technology, Conifer, Editas, Ensysce, Ev, Eversana, Gilead, Immvira, Lodo, Moderna, Mucokinetica, Novavax, Nura, Pfizer, Shanghai Pharmaceuticals, Takeda, Yulong, Zosano.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Biogen, Canbridge, Cytodyn, Eisai, Intellia, Kazia, PTC, Roche, Viiv.